Eric Schadt

Eric Schadt is a highly accomplished individual with a diverse range of experience in the field of genomics and healthcare. Eric currently holds the position of CSO at Pathos, starting in November 2022. Prior to this, they served as Professor/Dean for Precision Medicine at the Icahn School of Medicine at Mount Sinai from 2017 to an unknown date. Eric also held multiple roles at the institution, including Founding Director of the Icahn Institute for Genomics & Multiscale Biology and Chair of the Department of Genetics and Genomic Sciences from 2011 to 2017.

Schadt was a Co-Founder and Board Member of Sage Bionetworks starting from January 2009. In the field of biotechnology, they held the position of Founder, President, and Chief R&D Officer at Sema4 from May 2022 to August 2022. Eric previously held the role of Founder and CEO at Sema4, where they played a crucial role in advancing healthcare through data-driven insights using AI and machine learning.

Furthermore, Schadt served as the Chief Scientific Officer at Pacific Biosciences from May 2009 to July 2012. Prior to this, they held the position of Executive Director at Merck from July 2001 to May 2009. Eric also gained experience as the Chief Scientist at Rosetta Inpharmatics from November 1999 to July 2001 and as a Senior Research Scientist at Roche Bioscience from February 1998 to November 1999.

Eric Schadt received their Bachelor of Science degree in Applied Mathematics and Computer Science from California Polytechnic State University-San Luis Obispo in the years 1986 to 1991. Eric then pursued a Master of Arts in Pure Mathematics at the University of California, Davis from 1992 to 1993. Subsequently, they attended UCLA from 1993 to 1999, where they obtained their PhD in Biomathematics. Prior to their higher education, they earned their High School Degree from Lakeshore High School in the years 1979 to 1983. It is not specified if they undertook any studies at the University of Oregon.